MoonLake Immunotherapeutics (MLTX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday.

Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced the completion of the dosing and initial follow-up period for ...

Global Healthy Living Foundation has 12 posters and Polymyalygia Rheumataca, Psoriasis and RA Research at American College of ...

The following is a summary of “Association between depression and anxiety and inability to achieve remission in rheumatoid ...

“Seeking treatment is a very ... “There are many options to treat psoriatic arthritis, like COSENTYX, which may help provide relief and reduce symptoms. As a healthcare professional, I ...

Similar percentages of patients with PsA receiving secukinumab vs adalimumab achieved an ACR20 response at 12 weeks.

should be the target of all treatment strategies in psoriatic arthritis. All musculoskeletal and cutaneous manifestations of psoriatic disease need to be considered in treatment targets.

Exacerbations of the chronic and progressive inflammatory disease bronchiectasis can impact quality of life. Treatment, based ...

Treatment persistence varied by biologic therapy use, sex, and diagnostic codes among patients with psoriasis.

Researchers at the University of Massachusetts Amherst have invented a new, sprayable delivery system for psoriasis ...

A young woman who isn’t expected to live past 50 is hitting out at NDIS funding claiming decisions being made are a “mind ...